What is William Blair's Forecast for PRVA Q3 Earnings?

Key Points

• William Blair has revised its Q3 2025 EPS estimate for Privia Health Group from $0.06 to $0.07, indicating a positive outlook for the company's earnings.
• Privia Health Group reported Q2 earnings of $0.02 per share, missing analysts' expectations, but achieved a revenue of $521.15 million, surpassing consensus estimates significantly.
• As of the latest reports, Privia Health Group enjoys a consensus rating of "Moderate Buy" among analysts, with several raising their price targets for the stock.

Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) - William Blair upped their Q3 2025 earnings estimates for shares of Privia Health Group in a research note issued on Thursday, August 28th. William Blair analyst R. Daniels now anticipates that the company will earn $0.07 per share for the quarter, up from their prior forecast of $0.06. The consensus estimate for Privia Health Group's current full-year earnings is $0.14 per share. William Blair also issued estimates for Privia Health Group's Q4 2025 earnings at $0.08 EPS, FY2025 earnings at $0.21 EPS, Q4 2026 earnings at $0.09 EPS and FY2026 earnings at $0.32 EPS.

Privia Health Group (NASDAQ:PRVA - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The company reported $0.02 EPS for the quarter, missing analysts' consensus estimates of $0.05 by ($0.03). The company had revenue of $521.15 million for the quarter, compared to analyst estimates of $466.97 million. Privia Health Group had a net margin of 0.78% and a return on equity of 2.13%. The company's revenue was up 23.4% compared to the same quarter last year. During the same period in the prior year, the company earned $0.19 EPS. Privia Health Group has set its FY 2025 guidance at EPS.

A number of other research firms also recently issued reports on PRVA. Barclays increased their target price on shares of Privia Health Group from $23.00 to $24.00 and gave the stock an "equal weight" rating in a research report on Tuesday, May 27th. Stephens reissued an "overweight" rating and set a $32.00 target price on shares of Privia Health Group in a research report on Thursday. Zacks Research raised shares of Privia Health Group from a "strong sell" rating to a "hold" rating in a research report on Tuesday, August 19th. JMP Securities increased their target price on shares of Privia Health Group from $29.00 to $30.00 and gave the stock a "market outperform" rating in a research report on Friday, August 29th. Finally, Citigroup reissued an "outperform" rating on shares of Privia Health Group in a research report on Friday, August 29th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, Privia Health Group presently has a consensus rating of "Moderate Buy" and an average target price of $28.58.

Privia Health Group Stock Performance

PRVA traded up $0.16 on Monday, reaching $23.28. 1,195,157 shares of the company's stock were exchanged, compared to its average volume of 769,728. The company's 50 day moving average is $21.04 and its 200-day moving average is $22.60. The company has a market cap of $2.86 billion, a price-to-earnings ratio of 211.66, a PEG ratio of 3.35 and a beta of 0.82. Privia Health Group has a twelve month low of $16.47 and a twelve month high of $26.09.

Institutional Investors Weigh In On Privia Health Group

Hedge funds have recently added to or reduced their stakes in the stock. CWM LLC increased its holdings in shares of Privia Health Group by 50.3% during the first quarter. CWM LLC now owns 1,804 shares of the company's stock valued at $40,000 after purchasing an additional 604 shares during the period. Bessemer Group Inc. increased its holdings in shares of Privia Health Group by 2,393.4% during the first quarter. Bessemer Group Inc. now owns 2,269 shares of the company's stock valued at $51,000 after purchasing an additional 2,178 shares during the period. Russell Investments Group Ltd. increased its holdings in shares of Privia Health Group by 2,852.2% during the first quarter. Russell Investments Group Ltd. now owns 2,657 shares of the company's stock valued at $60,000 after purchasing an additional 2,567 shares during the period. GAMMA Investing LLC increased its holdings in shares of Privia Health Group by 113.1% during the first quarter. GAMMA Investing LLC now owns 2,866 shares of the company's stock valued at $64,000 after purchasing an additional 1,521 shares during the period. Finally, Caitong International Asset Management Co. Ltd increased its holdings in shares of Privia Health Group by 2,115.3% during the first quarter. Caitong International Asset Management Co. Ltd now owns 3,323 shares of the company's stock valued at $75,000 after purchasing an additional 3,173 shares during the period. 94.48% of the stock is currently owned by institutional investors.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.